AIMDW
Ainos, Inc.
Key Financials
Operating Income
$-13990408
↓ 1.1%
Net Income
$-14771012
↑ 0.6%
Gross Profit
$102911
↑ 422.9%
Revenue
$124157
↑ 499.0%
EPS (Diluted)
$-3.46
↓ 121.8%
Total Assets
$20.9M
↓ 27.6%
Total Liabilities
$13.3M
↑ 0.0%
Shareholders' Equity
$7.6M
↓ 51.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 4/17/2026 | View on SEC |
| SCHEDULE 13D/A | 4/17/2026 | View on SEC |
| SCHEDULE 13D/A | 4/17/2026 | View on SEC |
| 4 | 4/17/2026 | View on SEC |
| 4 | 4/17/2026 | View on SEC |
| 4 | 4/17/2026 | View on SEC |
| 4 | 4/15/2026 | View on SEC |
| SCHEDULE 13D/A | 4/15/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AIMDW |
| Company Name | Ainos, Inc. |
| CIK | 1014763 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | TX |
| Phone | (281) 898-6586 |